Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Sanofi (CIK 1121404) reported $534.0M across 10 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: MGTX ($164.8M, 30.86%), INBX ($109.7M, 20.54%), NVAX ($64.8M, 12.14%), ANAB ($55.5M, 10.39%), ODTX ($37.3M, 6.98%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MGTX | MeiraGTx Holdings plc | $164.8M | 30.86% | 12.2M | Hold |
| 2 | INBX | Inhibrx Biosciences, Inc. | $109.7M | 20.54% | 1.2M | Hold |
| 3 | NVAX | Novavax | $64.8M | 12.14% | 6.9M | Hold |
| 4 | ANAB | AnaptysBio | $55.5M | 10.39% | 821,917 | Hold |
| 5 | ODTX | Odyssey Therapeutics Inc. | $37.3M | 6.98% | 2.0M | New |
| 6 | AGMB | Agomab Therapeutics NV | $36.1M | 6.76% | 2.8M | Hold |
| 7 | MPLT | MapLight Therapeutics Inc. | $32.7M | 6.12% | 912,041 | Hold |
| 8 | TRAX | First Tracks Biotherapeutics Inc. | $16.5M | 3.10% | 821,917 | New |
| 9 | IMRX | Immuneering Corp | $13.5M | 2.53% | 2.7M | Hold |
| 10 | QTTB | Q32 Bio Inc. | $3.1M | 0.58% | 244,083 | Hold |
| 11 | ELDN | Eledon | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30